Catherine Skari
-
Sep- 2026 -7 SeptemberScientific Literature
Neutropenia in Adult Patients with Thalassemia Receiving Deferiprone: A 10-Year Experience From a Large Thalassemia Cohort
Background: Deferiprone (DFP) is an effective oral iron chelator widely used in adult patients with thalassemia, particularly for cardiac iron…
Read More » -
7 SeptemberScientific Literature
Atrial Fibrillation Prevalence and its Management in Aging, Transfusion-Dependent Patients with Thalassemia: The FATHAL Study
Abstract Atrial fibrillation (AF) represents an emerging challenge in thalassemia due to the increasing life expectancy. However, data are limited,…
Read More » -
7 SeptemberScientific Literature
MRI-Derived Hepatic Fat and its Clinical Correlates in Non–Transfusion-Dependent Thalassemia: A Cross-Sectional Study
Abstract We quantified hepatic fat fraction (FF) by magnetic resonance imaging (MRI) in non–transfusion-dependent thalassemia (NTDT) patients, and we evaluated…
Read More » -
7 SeptemberScientific Literature
The Shifting Global Thalassemia Burden and Lessons from Chinese Integrated Control Strategy
Thalassemias impose a substantial but highly uneven global health burden. Using Global Burden of Disease 2023 estimates, we quantified the…
Read More » -
7 SeptemberScientific Literature
Beta‐Thalassemia in Spain: Results From the National Thalassemia Registry and Molecular Analysis of Patients With Transfusion‐Dependent Thalassemia
ABSTRACT Background: Beta-thalassemia is a genetically heterogeneous hemoglobinopathy with marked clinical variability. In Spain, comprehensive nationwide data on transfusion-dependent beta-thalassemia…
Read More » -
7 SeptemberScientific Literature
Recent Advances in Thalassemia Management: From Curative Therapies to Artificial Intelligence
Abstract Thalassemia is an inherited hemoglobin disorder characterized by chronic hemolytic anemia and substantial long-term healthcare needs. In β-thalassemia major,…
Read More » -
7 SeptemberScientific Literature
A Multi-Center Clinical Trial of Allogeneic Hematopoietic Stem Cell Transplantation in Transfusion-Dependent Thalassemia
Allogeneic stem cell transplantation (allo-HSCT) has recently been approved as standard therapy for transfusion-dependent thalassemia (TDT) but remains limited to…
Read More » -
6 SeptemberNews
TIF WEBINAR SERIES 2026 | Bridging the Communication Gap in Haemoglobinopathy Care
This year, the Thalassaemia International Federation (TIF) launches a transformative quarterly webinar series designed to strengthen dialogue between patients, families,…
Read More » -
Aug- 2026 -28 AugustNews
WORLD PATIENT SAFETY DAY 2026 | Safe Care for Life
[/vc_row] Every person has the right to receive care that is safe, effective, respectful and centred on their needs. Yet…
Read More » -
28 AugustNews
WARM AUTOIMMUNE HAEMOLYTIC ANAEMIA | FDA Approves First Disease-Specific Treatment
Warm autoimmune haemolytic anaemia is an acquired autoimmune disorder in which immunoglobulin G (IgG) autoantibodies mistakenly attach to red blood…
Read More »